Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial. (2022)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jinf.2022.04.018

PubMed Identifier: 35405168

Publication URI: http://europepmc.org/abstract/MED/35405168

Type: Journal Article/Review

Parent Publication: Journal of Infection

Issue: 6

ISSN: 0163-4453